Health
Advancing the Diagnosis and Treatment of Ovarian Cancer – News-Medical.net
In this interview, News-Medical talks to Dr. Marcos Quintela Vasquez about the work he is conducting
regarding the diagnosis and treatment of ovarian cancer in…
In this interview, News-Medical talks to Dr. Marcos Quintela Vasquez about the work he is conducting regarding the diagnosis and treatment of ovarian cancer in partnership with CEAT and Porvair Sciences.
Please tell us about CEAT, your project aims and how the group of partners was assembled?
The Cluster for Epigenomic and Antibody Drug Conjugate (ADC) Therapeutics (CEAT) is a Swansea University-led partnership between key multi-national players Glaxo Smith Kline (GSK), Cytiva and Bruker, together…
-
Business24 hours agoWhy these are 2 of the most exciting ASX 300 shares to buy right now
-
Noosa News23 hours agoInside the illegal tobacco trade —secret rooms, fire bombings and bags full of cash
-
Business21 hours agoThese ASX 200 shares could rise 15% to 20%
-
Business20 hours agoEvery ASX 200 sector closed in the red last week. Here’s why